生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | NVP-AEW541 (AEW541) is an orally active inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) with an IC50 of 0.15 μM. It also inhibits the insulin receptor (InsR) with an IC50 of 0.14 μM, showcasing significant antitumor activity[1]. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
32D-Bcr-Abl | ~10 μM | Kinase assay | inhibits Bcr-Abl p210 with IC50 of >10 μM | 15050915 | |
6647 | ~7 μM | Growth inhibitory assay | IC50<0.5 μM | 15867386 | |
A14 | ~10 μM | Kinase assay | inhibits InsR with IC50 of 2.3 ± 0.163 μM | 15050915 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.28mL 0.46mL 0.23mL |
11.38mL 2.28mL 1.14mL |
22.75mL 4.55mL 2.28mL |
参考文献 |
---|